About
Robin Mansukhani is a San Francisco-based biotech entrepreneur best known as CEO and co-founder of Deciduous Therapeutics, which develops immunotherapies for age-related diseases. He previously co-founded and led Alzeca Biosciences, an Alzheimer's/CNS diagnostic imaging company, and earlier worked in early-stage venture capital at The Maple Fund and in investment banking at Axiom Capital. Public sources also describe him as a speaker, startup advisor, and mentor in the biotech and longevity ecosystem.
Areas of interest
longevitybiotechimmunotherapyaging biologyAlzheimer's diseaseCNS diagnosticsneurodegenerative diseasediabetesengineering educationentrepreneurshipearly-stage startupsventure capitalhealth span